Insider Trading - Cerevel Therapeutics Holdings Inc. (CERE)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Cerevel Therapeutics Holdings Inc.
Goto 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-10-27
Purchase
2020-10-29
8:00 pm
Cerevel Therapeutics Holdings Inc. CERE Gordon Christopher R
Director
10% Owner
10,000,000 $10 $100,000,000 110,262,006
(Indirect)
View
2020-10-27
Purchase
2020-10-29
8:00 pm
Cerevel Therapeutics Holdings Inc. CERE BAIN CAPITAL INVESTORS LLC
BC Perception Holdings LP
BCPE Perception GP LLC
Bain Capital Fund XII LP
Bain Capital Partners XII LLC
10% Owner
10,000,000 $10 $100,000,000 60,300,063
(Indirect)
View
2020-10-27
Purchase
2020-10-29
8:00 pm
Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
Director
10% Owner
10,000,000 $10 $100,000,000 110,262,006
(Indirect)
View
2020-10-27
Purchase
2020-10-29
8:00 pm
Cerevel Therapeutics Holdings Inc. CERE PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
3,000,000 $10 $30,000,000 3,157,295
(Indirect)
View
2020-11-09
Purchase
2020-11-12
5:51 pm
Cerevel Therapeutics Holdings Inc. CERE Gordon Christopher R
Director
10% Owner
332,293 $10.3 $3,422,618 60,632,356
(Indirect)
View
2020-11-09
Purchase
2020-11-12
5:54 pm
Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
Director
10% Owner
332,293 $10.3 $3,422,618 60,632,356
(Indirect)
View
2020-11-09
Purchase
2020-11-12
5:54 pm
Cerevel Therapeutics Holdings Inc. CERE BAIN CAPITAL INVESTORS LLC
BC Perception Holdings LP
BCPE Perception GP LLC
Bain Capital Fund XII LP
Bain Capital Partners XII LLC
10% Owner
332,293 $10.3 $3,422,618 60,632,356
(Indirect)
View
2021-06-17
Purchase
2021-06-22
6:31 pm
Cerevel Therapeutics Holdings Inc. CERE Sulzberger Gabrielle
Director
21,084 $13.06 $275,357 35,354
(Direct)
View
2021-07-07
Purchase
2021-07-09
6:39 pm
Cerevel Therapeutics Holdings Inc. CERE PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
200,000 $25 $5,000,000 4,843,095
(Indirect)
View
2021-08-23
Purchase
2021-08-25
7:14 pm
Cerevel Therapeutics Holdings Inc. CERE PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
175,585 $27.53 $4,833,885 5,018,680
(Indirect)
View
2021-08-26
Purchase
2021-08-31
2:15 pm
Cerevel Therapeutics Holdings Inc. CERE PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
Director
68,047 $30.23 $2,057,061 5,086,727
(Indirect)
View
2021-11-10
Sale
2021-11-15
4:18 pm
Cerevel Therapeutics Holdings Inc. CERE Renger John
Chief Scientific Officer
55,000 $39.86 $2,192,187 425,875
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-10-27
Other
2020-10-29
8:00 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE Gordon Christopher R
Director
10% Owner
49,961,943 $0 110,262,006
(Indirect)
View
2020-10-27
Other
2020-10-29
8:00 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
Director
10% Owner
49,961,943 $0 110,262,006
(Indirect)
View
2020-10-28
Option Award
2020-10-30
8:13 pm
N/A
2030-10-28
Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
CEO
196,335 $0 196,335
(Direct)
View
2020-10-28
Option Award
2020-10-30
8:13 pm
N/A
2030-10-28
Cerevel Therapeutics Holdings Inc. CERE Bodenrader Mark
See Remarks
65,445 $0 65,445
(Direct)
View
2020-10-28
Option Award
2020-10-30
8:14 pm
N/A
2030-10-28
Cerevel Therapeutics Holdings Inc. CERE Renger John
Chief Scientific Officer
117,801 $0 117,801
(Direct)
View
2020-10-28
Option Award
2020-10-30
8:18 pm
N/A
2030-10-28
Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer
130,890 $0 130,890
(Direct)
View
2020-10-28
Option Award
2020-10-30
8:19 pm
N/A
2030-10-28
Cerevel Therapeutics Holdings Inc. CERE Yi Kathy
CFO
78,534 $0 78,534
(Direct)
View
2020-12-04
Option Award
2020-12-08
7:05 pm
N/A
2030-12-04
Cerevel Therapeutics Holdings Inc. CERE Tregoning Kathleen
See Remarks
78,229 $0 78,229
(Direct)
View
2021-01-04
Exercise
2021-01-06
4:26 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE RIEDEL NORBERT G
Director
14,270 $0 42,810
(Direct)
View
2021-01-04
Option Award
2021-01-11
5:06 pm
N/A
2031-01-04
Cerevel Therapeutics Holdings Inc. CERE Mckernan Ruth
Director
80,945 $0 80,945
(Direct)
View
2021-01-25
Exercise
2021-01-28
7:35 pm
N/A
2029-06-25
Cerevel Therapeutics Holdings Inc. CERE MISHAN ORLY
Chief Business Officer
38,450 $0 465,363
(Direct)
View
2021-01-25
Exercise
2021-01-28
7:35 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE MISHAN ORLY
Chief Business Officer
38,450 $3.5 465,363
(Direct)
View
2021-02-01
Option Award
2021-02-03
7:19 pm
N/A
2031-02-01
Cerevel Therapeutics Holdings Inc. CERE Baron Deborah
Director
90,390 $0 90,390
(Direct)
View
2021-02-01
Option Award
2021-02-03
7:28 pm
N/A
2031-02-01
Cerevel Therapeutics Holdings Inc. CERE PATRICK DEVAL L
Director
90,390 $0 90,390
(Direct)
View
2021-02-03
Option Award
2021-02-05
6:42 pm
N/A
2031-02-03
Cerevel Therapeutics Holdings Inc. CERE Yi Kathy
CFO
216,718 $0 216,718
(Direct)
View
2021-02-03
Option Award
2021-02-05
6:45 pm
N/A
2031-02-03
Cerevel Therapeutics Holdings Inc. CERE DiPietro Kenneth
Chief Human Resources Officer
175,438 $0 175,438
(Direct)
View
2021-02-03
Option Award
2021-02-05
6:46 pm
N/A
2031-02-03
Cerevel Therapeutics Holdings Inc. CERE Bodenrader Mark
See Remarks
90,000 $0 90,000
(Direct)
View
2021-02-03
Option Award
2021-02-05
6:47 pm
N/A
2031-02-03
Cerevel Therapeutics Holdings Inc. CERE COLES N ANTHONY
CEO
732,714 $0 732,714
(Direct)
View
2021-02-03
Option Award
2021-02-05
6:50 pm
N/A
2031-02-03
Cerevel Therapeutics Holdings Inc. CERE Tregoning Kathleen
See Remarks
77,399 $0 77,399
(Direct)
View
2021-02-03
Option Award
2021-02-05
6:51 pm
N/A
2031-02-03
Cerevel Therapeutics Holdings Inc. CERE Renger John
Chief Scientific Officer
247,678 $0 247,678
(Direct)
View
2021-02-03
Option Award
2021-02-05
6:56 pm
N/A
2031-02-03
Cerevel Therapeutics Holdings Inc. CERE Sanchez Ramiro
Chief Medical Officer
278,637 $0 278,637
(Direct)
View
2021-06-01
Option Award
2021-06-03
4:24 pm
N/A
2031-06-01
Cerevel Therapeutics Holdings Inc. CERE Ceesay Abraham
President
461,065 $0 461,065
(Direct)
View
2021-06-01
Option Award
2021-06-03
4:34 pm
N/A
2031-06-01
Cerevel Therapeutics Holdings Inc. CERE Akamine Scott
Chief Legal Officer
281,762 $0 281,762
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:04 pm
N/A
2031-06-10
Cerevel Therapeutics Holdings Inc. CERE Giordano Douglas E.
Director
58,003 $0 58,003
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:09 pm
N/A
2031-06-10
Cerevel Therapeutics Holdings Inc. CERE DEKKERS MARIJN E
Director
58,003 $0 58,003
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:11 pm
N/A
2031-06-10
Cerevel Therapeutics Holdings Inc. CERE Sulzberger Gabrielle
Director
58,003 $0 58,003
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:14 pm
N/A
2031-06-10
Cerevel Therapeutics Holdings Inc. CERE RIEDEL NORBERT G
Director
58,003 $0 58,003
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:25 pm
N/A
2031-06-10
Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
Director
10% Owner
42,950 $0 42,950
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:26 pm
N/A
2031-06-10
Cerevel Therapeutics Holdings Inc. CERE Gordon Christopher R
Director
10% Owner
42,950 $0 42,950
(Direct)
View
2021-06-24
Exercise
2021-06-24
5:32 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE Sulzberger Gabrielle
Director
14,270 $0 63,894
(Direct)
View
2021-09-24
Exercise
2021-09-28
4:10 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE DEKKERS MARIJN E
Director
14,270 $0 676,160
(Direct)
View
2021-11-10
Exercise
2021-11-15
4:18 pm
N/A
2029-04-02
Cerevel Therapeutics Holdings Inc. CERE Renger John
Chief Scientific Officer
55,000 $0 425,875
(Direct)
View
2021-11-10
Exercise
2021-11-15
4:18 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc. CERE Renger John
Chief Scientific Officer
55,000 $3.5 425,875
(Direct)
View
Goto 0, 1, Next